JEFFS ROGER

SEC CIK
0001231615

Latest role at each company

Trades

Every Form 4 that lists JEFFS ROGER as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Insider trades
CompanyFiled (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
LQDALiquidia CorpJul 14, 20268:07 PM ETJul 13, 2026JEFFS ROGERChief Executive OfficerSSaleCommon Stock−35.25K$71.5108−$2.52M1.13M−3.0%SEC10b5-1
AXSMAxsome Therapeutics, Inc.Jun 11, 2026Jun 10 – Jun 11, 2026JEFFS ROGERDirectorSSaleCommon Stock−572$247.65−$141.66K58.37K−1.0%SEC10b5-1
LQDALiquidia CorpMay 28, 2026May 27, 2026JEFFS ROGERChief Executive OfficerSSaleCommon Stock−6.43K$62.18−$399.69K1.04M−0.6%SEC10b5-1
LQDALiquidia CorpMay 26, 2026May 21 – May 26, 2026JEFFS ROGERChief Executive OfficerSSaleCommon Stock−75K$61.01−$4.58M1.05M−6.7%SEC10b5-1
LQDALiquidia CorpMay 20, 2026May 18 – May 20, 2026JEFFS ROGERChief Executive OfficerSSaleCommon Stock−75K$58.9067−$4.42M1.12M−6.3%SEC10b5-1
LQDALiquidia CorpMay 15, 2026May 13 – May 15, 2026JEFFS ROGERChief Executive OfficerSSaleCommon Stock−75K$57.3167−$4.3M1.2M−5.9%SEC10b5-1
LQDALiquidia CorpMay 12, 2026May 8 – May 12, 2026JEFFS ROGERChief Executive OfficerSSaleCommon Stock−75K$45.8933−$3.44M1.27M−5.6%SEC10b5-1
LQDALiquidia CorpMay 7, 2026May 5 – May 7, 2026JEFFS ROGERChief Executive OfficerSSaleCommon Stock−75K$40.99−$3.07M1.35M−5.3%SEC10b5-1
LQDALiquidia CorpApr 21, 2026Apr 17, 2026JEFFS ROGERChief Executive OfficerSSaleCommon Stock−18.84K$40.60−$764.86K1.42M−1.3%SEC10b5-1
LQDALiquidia CorpApr 16, 2026Apr 14 – Apr 16, 2026JEFFS ROGERChief Executive OfficerSSaleCommon Stock−53.3K$40.2111−$2.14M1.44M−3.6%SEC10b5-1
LQDALiquidia CorpApr 14, 2026Apr 13, 2026JEFFS ROGERChief Executive OfficerSSaleCommon Stock−32.74K$38.37−$1.26M1.14M−2.8%SEC10b5-1
LQDALiquidia CorpApr 14, 2026Apr 10, 2026JEFFS ROGERChief Executive OfficerSSaleCommon Stock−21.43K$40.12−$859.89K1.5M−1.4%SEC10b5-1
LQDALiquidia CorpApr 13, 2026Apr 9, 2026JEFFS ROGERChief Executive OfficerSSaleCommon Stock−25K$40.12−$1M1.52M−1.6%SEC10b5-1
LQDALiquidia CorpJan 13, 2026Jan 12, 2026JEFFS ROGERChief Executive OfficerSSaleCommon Stock−66.61K$37.43−$2.49M1.04M−6.0%SEC10b5-1
LQDALiquidia CorpOct 15, 2025Oct 13, 2025JEFFS ROGERChief Executive OfficerSSaleCommon Stock−20.26K$23.41−$474.31K1.03M−1.9%SEC10b5-1
AXSMAxsome Therapeutics, Inc.Sep 2, 2025Sep 2, 2025JEFFS ROGERDirectorSSaleCommon Stock−13.46K$123.68−$1.67M57.51K−19.0%SEC10b5-1
AXSMAxsome Therapeutics, Inc.Aug 29, 2025Aug 27 – Aug 29, 2025JEFFS ROGERDirectorSSaleCommon Stock−60K$121.7233−$7.3M70.97K−45.8%SEC10b5-1
AXSMAxsome Therapeutics, Inc.Aug 26, 2025Aug 22 – Aug 26, 2025JEFFS ROGERDirectorSSaleCommon Stock−36.69K$120.0527−$4.41M130.97K−21.9%SEC10b5-1
LQDALiquidia CorpJul 15, 2025Jul 14, 2025JEFFS ROGERChief Executive OfficerSSaleCommon Stock−20.25K$14.28−$289.2K1.04M−1.9%SEC10b5-1
LQDALiquidia CorpJul 15, 2025Jul 14, 2025JEFFS ROGERChief Executive OfficerSSaleCommon Stock−20.25K$14.28−$289.2K1.04M−1.9%SEC10b5-1
LQDALiquidia CorpJun 5, 2025Jun 4, 2025JEFFS ROGERChief Executive OfficerSSaleCommon Stock−30.61K$16.97−$519.45K1.04M−2.8%SEC10b5-1
LQDALiquidia CorpApr 16, 2025Apr 14, 2025JEFFS ROGERChief Executive OfficerSSaleCommon Stock−14.13K$13.57−$191.74K1.01M−1.4%SEC10b5-1
LQDALiquidia CorpJan 14, 2025Jan 14, 2025JEFFS ROGERChief Executive OfficerSSaleCommon Stock−22.34K$11.78−$263.2K1.02M−2.1%SEC10b5-1
LQDALiquidia CorpOct 15, 2024Oct 14, 2024JEFFS ROGERChief Executive OfficerSSaleCommon Stock−8.05K$11.11−$89.47K812.19K−1.0%SEC10b5-1
LQDALiquidia CorpJul 15, 2024Jul 12, 2024JEFFS ROGERChief Executive OfficerSSaleCommon Stock−8.05K$12.53−$100.9K818.93K−1.0%SEC10b5-1
LQDALiquidia CorpApr 16, 2024Apr 12, 2024JEFFS ROGERChief Executive OfficerSSaleCommon Stock−8.36K$14.58−$121.89K826.99K−1.0%SEC10b5-1
LQDALiquidia CorpMar 19, 2024Mar 18, 2024JEFFS ROGERChief Executive OfficerSSaleCommon Stock−28.58K$15.82−$452.18K835.35K−3.3%SEC10b5-1
AXSMAxsome Therapeutics, Inc.Mar 15, 2024Mar 14 – Mar 15, 2024JEFFS ROGERDirectorSSaleCommon Stock−32.32K$69.8387−$2.26M120.76K−21.1%SEC10b5-1
LQDALiquidia CorpDec 18, 2023Dec 14, 2023JEFFS ROGERChief Executive OfficerPPurchaseCommon Stock+139.67K$7.16+$1M640.81K+27.9%SEC
LQDALiquidia CorpSep 7, 2022Sep 6, 2022JEFFS ROGERChief Executive OfficerPPurchaseCommon Stock+43.82K$5.57+$244.08K159.83K+37.8%SEC
LQDALiquidia CorpMay 25, 2022May 24, 2022JEFFS ROGERChief Executive OfficerPPurchaseCommon Stock+28K$3.53+$98.84K46.6K+150.6%SEC
AXSMAxsome Therapeutics, Inc.Nov 23, 2021Nov 19, 2021JEFFS ROGERDirectorPPurchaseCommon Stock+3.95K$37.30+$147.34K120.76K+3.4%SEC